BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 29398447)

  • 1. Transcriptional Pause Sites Delineate Stable Nucleosome-Associated Premature Polyadenylation Suppressed by U1 snRNP.
    Chiu AC; Suzuki HI; Wu X; Mahat DB; Kriz AJ; Sharp PA
    Mol Cell; 2018 Feb; 69(4):648-663.e7. PubMed ID: 29398447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter directionality is controlled by U1 snRNP and polyadenylation signals.
    Almada AE; Wu X; Kriz AJ; Burge CB; Sharp PA
    Nature; 2013 Jul; 499(7458):360-3. PubMed ID: 23792564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. U1 snRNP increases RNA Pol II elongation rate to enable synthesis of long genes.
    Mimoso CA; Adelman K
    Mol Cell; 2023 Apr; 83(8):1264-1279.e10. PubMed ID: 36965480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The U1 antisense morpholino oligonucleotide (AMO) disrupts U1 snRNP structure to promote intronic PCPA modification of pre-mRNAs.
    Feng Q; Lin Z; Deng Y; Ran Y; Yu R; Xiang AP; Ye C; Yao C
    J Biol Chem; 2023 Jul; 299(7):104854. PubMed ID: 37224962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient RNA polymerase II pause release requires U2 snRNP function.
    Caizzi L; Monteiro-Martins S; Schwalb B; Lysakovskaia K; Schmitzova J; Sawicka A; Chen Y; Lidschreiber M; Cramer P
    Mol Cell; 2021 May; 81(9):1920-1934.e9. PubMed ID: 33689748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive RNP profiling in cells identifies U1 snRNP complexes with cleavage and polyadenylation factors active in telescripting.
    Cai Z; So BR; Dreyfuss G
    Methods Enzymol; 2021; 655():325-347. PubMed ID: 34183128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suboptimal RNA-RNA interaction limits U1 snRNP inhibition of canonical mRNA 3' processing.
    Shi J; Deng Y; Huang S; Huang C; Wang J; Xiang AP; Yao C
    RNA Biol; 2019 Oct; 16(10):1448-1460. PubMed ID: 31242075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative elongation factor (NELF) coordinates RNA polymerase II pausing, premature termination, and chromatin remodeling to regulate HIV transcription.
    Natarajan M; Schiralli Lester GM; Lee C; Missra A; Wasserman GA; Steffen M; Gilmour DS; Henderson AJ
    J Biol Chem; 2013 Sep; 288(36):25995-26003. PubMed ID: 23884411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. tRIP-seq reveals repression of premature polyadenylation by co-transcriptional FUS-U1 snRNP assembly.
    Masuda A; Kawachi T; Takeda JI; Ohkawara B; Ito M; Ohno K
    EMBO Rep; 2020 May; 21(5):e49890. PubMed ID: 32189459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elongation rate of RNA polymerase II affects pausing patterns across 3' UTRs.
    Khitun A; Brion C; Moqtaderi Z; Geisberg JV; Churchman LS; Struhl K
    J Biol Chem; 2023 Nov; 299(11):105289. PubMed ID: 37748648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A transcriptome-wide antitermination mechanism sustaining identity of embryonic stem cells.
    Kainov YA; Makeyev EV
    Nat Commun; 2020 Jan; 11(1):361. PubMed ID: 31953406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potential mechanism underlying U1 snRNP inhibition of the cleavage step of mRNA 3' processing.
    Deng Y; Shi J; Ran Y; Xiang AP; Yao C
    Biochem Biophys Res Commun; 2020 Sep; 530(1):196-202. PubMed ID: 32828285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable pausing by RNA polymerase II provides an opportunity to target and integrate regulatory signals.
    Henriques T; Gilchrist DA; Nechaev S; Bern M; Muse GW; Burkholder A; Fargo DC; Adelman K
    Mol Cell; 2013 Nov; 52(4):517-28. PubMed ID: 24184211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN modulates gene transcription by redistributing genome-wide RNA polymerase II occupancy.
    Abbas A; Padmanabhan R; Romigh T; Eng C
    Hum Mol Genet; 2019 Sep; 28(17):2826-2834. PubMed ID: 31127935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nucleosome regulates the usage of polyadenylation sites in the human genome.
    Huang H; Chen J; Liu H; Sun X
    BMC Genomics; 2013 Dec; 14():912. PubMed ID: 24365105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Directing transcription to the right way.
    Huang F; Workman JL
    Cell Res; 2013 Oct; 23(10):1153-4. PubMed ID: 23896985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FACT maintains chromatin architecture and thereby stimulates RNA polymerase II pausing during transcription in vivo.
    Žumer K; Ochmann M; Aljahani A; Zheenbekova A; Devadas A; Maier KC; Rus P; Neef U; Oudelaar AM; Cramer P
    Mol Cell; 2024 Jun; 84(11):2053-2069.e9. PubMed ID: 38810649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. U1 interference (U1i) for antiviral approaches.
    Blázquez L; Fortes P
    Adv Exp Med Biol; 2015; 848():51-69. PubMed ID: 25757615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. U1 snRNP-mediated poly(A) site suppression: beneficial and deleterious for mRNA fate.
    Langemeier J; Radtke M; Bohne J
    RNA Biol; 2013 Feb; 10(2):180-4. PubMed ID: 23324605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Widespread Backtracking by RNA Pol II Is a Major Effector of Gene Activation, 5' Pause Release, Termination, and Transcription Elongation Rate.
    Sheridan RM; Fong N; D'Alessandro A; Bentley DL
    Mol Cell; 2019 Jan; 73(1):107-118.e4. PubMed ID: 30503775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.